Articles Posted in Mass Torts

You may be here because you or someone in your family has been diagnosed with acute myeloid leukemia (AML) or another blood cancer after years of benzene exposure. Benzene lawsuits most often focus on AML and related blood cancers linked to workplace or product exposure. These conditions are devastating on their own. When they are tied to a toxic chemical like benzene, the frustration is even greater.

Benzene has been tied to cancer for decades. The research is clear. Workers have brought benzene exposure lawsuits across the country, and juries have awarded significant verdicts in many cases. Families have negotiated benzene lawsuit settlements after showing that their exposure on the job or in the community caused leukemia, multiple myeloma, or other blood-related diseases.

If you are considering a benzene lawsuit, you are likely wondering how the process works, whether your case qualifies, and what kind of compensation is possible. The answers are specific to your situation, but the starting point is always the same: understanding how exposure happens and how the law allows victims to bring claims.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

Glucose monitor lawsuits are being filed by people who say continuous glucose monitoring systems failed when they needed them most. These lawsuits involve Dexcom G6, Dexcom G7, Abbott FreeStyle Libre 3, and Abbott FreeStyle Libre 3 Plus sensors, apps, and receivers that allegedly provided inaccurate glucose readings, missed high- or low-glucose alerts, failed early, or failed to warn users that glucose data had stopped reporting.

This is no small complaint for someone with diabetes who relies on these monitors. A continuous glucose monitor can drive decisions about insulin, food, sleep, exercise, and emergency care. When a sensor falsely reports low glucose, a patient may eat carbohydrates or delay insulin. When a device misses a low alert, a patient may seize, lose consciousness, fall, or die. When a high glucose event is missed, the result can be prolonged hyperglycemia, diabetic ketoacidosis, hospitalization, or worse.  Of course, a malfunctioning glucose monitor typically causes more minor injuries and inconveniences.

Our lawyers are looking for serious glucose monitor cases involving serious injury or death.